Xuesong Liu Selected Research

Platinum

1/2022	Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer.
12/2020	Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuesong Liu Research Topics

Disease

52	Neoplasms (Cancer) 05/2024 - 01/2003
6	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 05/2016
6	Stomach Neoplasms (Stomach Cancer) 12/2021 - 01/2017
6	Melanoma (Melanoma, Malignant) 04/2010 - 07/2008
5	Inflammation (Inflammations) 01/2023 - 01/2011
5	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2006
4	Hypoxia (Hypoxemia) 02/2024 - 01/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2023
4	Infections 11/2023 - 01/2019
3	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 12/2019
3	Rheumatoid Arthritis 04/2024 - 01/2022
3	COVID-19 07/2021 - 12/2020
3	Fatigue 04/2021 - 04/2018
3	Colonic Neoplasms (Colon Cancer) 02/2021 - 01/2020
3	Carcinoma (Carcinomatosis) 01/2020 - 05/2007
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019 - 12/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2024 - 01/2024
2	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 12/2019
2	Takotsubo Cardiomyopathy 12/2023 - 11/2020
2	Wounds and Injuries (Trauma) 11/2023 - 07/2015
2	Wound Infection (Wound Infections) 11/2023 - 09/2022
2	Hemorrhage 01/2023 - 01/2015
2	Venous Thromboembolism 01/2023 - 01/2021
2	Esophageal Squamous Cell Carcinoma 01/2023 - 01/2022
2	Ischemic Stroke 01/2022 - 01/2013
2	Sepsis (Septicemia) 09/2021 - 11/2020
2	Pneumonia (Pneumonitis) 07/2021 - 01/2019
2	Wilms Tumor (Wilm's Tumor) 01/2019 - 01/2018
2	Pain (Aches) 07/2016 - 09/2012
2	Ascites 11/2013 - 07/2013
1	Viremia 01/2024

Drug/Important Bio-Agent (IBA)

11	Phosphotransferases (Kinase)IBA 09/2023 - 09/2004
11	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2020 - 05/2007
11	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 05/2007
9	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2006
7	CytokinesIBA 01/2024 - 01/2020
7	EnzymesIBA 11/2022 - 01/2009
7	veliparibIBA 09/2012 - 05/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 05/2007
4	PolymersIBA 01/2023 - 09/2008
4	Biomarkers (Surrogate Marker)IBA 02/2021 - 12/2018
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2020 - 07/2008
4	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 06/2007 - 03/2006
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 10/2016
3	LipidsIBA 01/2021 - 09/2019
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 05/2016
3	Poly Adenosine Diphosphate RiboseIBA 09/2012 - 10/2008
3	Carboplatin (JM8)FDA LinkGeneric 04/2010 - 05/2007
3	Cytotoxins (Cytolysins)IBA 11/2009 - 05/2007
2	venetoclaxIBA 05/2024 - 01/2024
2	Interleukin-6 (Interleukin 6)IBA 11/2023 - 02/2022
2	CholesterolIBA 11/2023 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 06/2005
2	SteroidsIBA 01/2023 - 10/2017
2	AntioxidantsIBA 01/2023 - 01/2021
2	NAD (NADH)IBA 11/2022 - 01/2012
2	Oxygen (Dioxygen)IBA 11/2022 - 11/2020
2	Interleukin-17 (Interleukin 17)IBA 02/2022 - 01/2022
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 05/2016
2	PlatinumIBA 01/2022 - 12/2020
2	LigandsIBA 01/2022 - 01/2017
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2021
2	MagnesiumIBA 04/2021 - 11/2020
2	AlloysIBA 04/2021 - 11/2020
2	Therapeutic UsesIBA 02/2021 - 07/2015
2	shikoninIBA 02/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 01/2019
2	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 11/2020
2	Neuroprotective AgentsIBA 11/2020 - 01/2013
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020 - 10/2019
2	Alkylating AgentsIBA 01/2020 - 06/2008
2	VaccinesIBA 01/2019 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2018 - 05/2016
2	FlagellinIBA 11/2013 - 07/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2009 - 05/2007
2	benzimidazoleIBA 01/2009 - 07/2008
2	Cisplatin (Platino)FDA LinkGeneric 07/2008 - 05/2007
2	pyridineIBA 06/2007 - 07/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2005 - 06/2005
2	Sirolimus (Rapamycin)FDA Link 06/2005 - 09/2004
1	glycyrrhizae radix et rhizomaIBA 04/2024
1	fuzi drug herbalIBA 04/2024
1	fibroblast activation protein alphaIBA 02/2024
1	Apoptosis Regulatory ProteinsIBA 01/2024
1	purineIBA 12/2023
1	chan su (ChanSu)IBA 12/2023
1	pyrimidineIBA 12/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	GTP-Binding Proteins (G-Protein)IBA 12/2023
1	Guanosine Diphosphate (GDP)IBA 12/2023
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2023

Therapy/Procedure

29	Therapeutics 02/2024 - 06/2005
8	Immunotherapy 09/2023 - 01/2017
6	Drug Therapy (Chemotherapy) 12/2021 - 10/2008
4	Artificial Respiration (Mechanical Ventilation) 09/2022 - 01/2020
4	Radiotherapy 01/2019 - 10/2008
2	Transurethral Resection of Prostate (TURP) 01/2023 - 01/2021
2	Lasers (Laser) 01/2020 - 01/2017
2	Adjuvant Chemotherapy 01/2020 - 10/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2023